in high throughput gene and pep- tide synthesis technologies have led to an explosion of high-resolution methods for the discovery of autoantigens and antigen surrogates. Daugherty and coworkers devel- oped a technology that capitalized on Escherichia coli dis- play of very large random peptide libraries for the identification of peptide motifs that bound to antibodies from patient sera.